[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CR11644A - Tratamiento para desordenes relacionados con los ojos - Google Patents

Tratamiento para desordenes relacionados con los ojos

Info

Publication number
CR11644A
CR11644A CR11644A CR11644A CR11644A CR 11644 A CR11644 A CR 11644A CR 11644 A CR11644 A CR 11644A CR 11644 A CR11644 A CR 11644A CR 11644 A CR11644 A CR 11644A
Authority
CR
Costa Rica
Prior art keywords
treatment
eye
related disorders
macular degeneration
diabetic
Prior art date
Application number
CR11644A
Other languages
English (en)
Inventor
Thomas Oligino
Chang Hahn
Timothy A Gillespy
Ramalinga Dharanipragada
Ellen Matzkin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR11644A publication Critical patent/CR11644A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describe un tratamiento para trastornos relacionados con los ojos, tales como la degeneracion macular, y preferentemente degeneracion macular asociada a la edad, retinopatia diabetica, y edema macular diabetico, utilizando un compuesto de Formula I.
CR11644A 2008-03-10 2010-08-24 Tratamiento para desordenes relacionados con los ojos CR11644A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10

Publications (1)

Publication Number Publication Date
CR11644A true CR11644A (es) 2010-11-22

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11644A CR11644A (es) 2008-03-10 2010-08-24 Tratamiento para desordenes relacionados con los ojos

Country Status (22)

Country Link
EP (1) EP2285378A1 (es)
JP (1) JP2011513488A (es)
KR (1) KR20110009084A (es)
CN (1) CN101965188A (es)
AR (1) AR070975A1 (es)
AU (1) AU2009223501A1 (es)
BR (1) BRPI0909659A2 (es)
CA (1) CA2717991A1 (es)
CL (1) CL2009000551A1 (es)
CO (1) CO6290691A2 (es)
CR (1) CR11644A (es)
DO (1) DOP2010000266A (es)
IL (1) IL207906A0 (es)
MA (1) MA32211B1 (es)
MX (1) MX2010008308A (es)
NI (1) NI201000131A (es)
NZ (1) NZ587906A (es)
RU (1) RU2010141560A (es)
SV (1) SV2010003658A (es)
TW (1) TW200950784A (es)
WO (1) WO2009114373A1 (es)
ZA (1) ZA201005337B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201034675A (en) 2008-12-18 2010-10-01 Sanofi Aventis Method for treating macular degeneration
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1917A (en) * 1999-12-24 2008-11-12 Aventis Pharma Ltd Azaindoles
WO2001062252A1 (en) * 2000-02-25 2001-08-30 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2007041358A2 (en) * 2005-09-30 2007-04-12 Miikana Therapeutics, Inc. Substituted pyrazole compounds
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
NI201000131A (es) 2011-09-29
CO6290691A2 (es) 2011-06-20
ZA201005337B (en) 2011-04-28
JP2011513488A (ja) 2011-04-28
MA32211B1 (fr) 2011-04-01
AU2009223501A1 (en) 2009-09-17
MX2010008308A (es) 2010-08-11
CL2009000551A1 (es) 2009-08-21
DOP2010000266A (es) 2010-09-30
AR070975A1 (es) 2010-05-19
RU2010141560A (ru) 2012-04-20
CA2717991A1 (en) 2009-09-17
KR20110009084A (ko) 2011-01-27
WO2009114373A1 (en) 2009-09-17
IL207906A0 (en) 2010-12-30
SV2010003658A (es) 2011-01-31
NZ587906A (en) 2011-12-22
CN101965188A (zh) 2011-02-02
BRPI0909659A2 (pt) 2015-09-22
TW200950784A (en) 2009-12-16
EP2285378A1 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
DOP2016000041A (es) Compuestos derivados de 5,5,7,7-tetrametil-5,7-dihidro-4h-tieno[2,3-c]piran-3-carboxamida que son moduladores del regulador de la conductancia transmembrana de la fibrosis quística (cftr)
CO6781507A2 (es) Novedosos derivados heterociclicos
MX2015005831A (es) Antagonistas de il-6 y usos de los mismos.
MY175318A (en) Androgen composition for treating an opthalmic condition
GT201400131A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
CU20120099A7 (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
CO6821960A2 (es) Benzoxazepinonas fusionadas como moduladoras de canales iónicos
ECSP12011720A (es) Compuestos heterocíclicos y usos de los mismos
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
EA201391561A1 (ru) Новые соединения-модуляторы gpr-119
BR112014008759A8 (pt) Tratamento de doença ocular
CR20140476A (es) Agentes para tratar transtornos que implican la modulación de receptores de rianodina
CO6771439A2 (es) Inhibidores de benzodioxano de la producción de leucotrieno
MX2013012211A (es) Derivados biciclicos substituidos de metil amina como moduladores de receptores de esfingosina-1-fosfato.
ECSP15029822A (es) Derivados de imidazopiridazina como moduladores del receptor gabaa
CO6660505A2 (es) Compuestos heterocíclicos, su preparación y su aplicación terapéutica
GT201400242A (es) "nuevos compuestos de pirazol"
DOP2013000304A (es) Moduladores alostéricos positivos del receptor de acetilcolina nicotínico
EA201491251A1 (ru) Соединение 2-(пиридин-2-ил)-1,7-диазаспиро[4.4]нонан-6-она в качестве модуляторов потенциалзависимых натриевых каналов
CR11644A (es) Tratamiento para desordenes relacionados con los ojos
CR20150143A (es) Derivados de etinilo como moduladores del receptor de actividad mglur5
CR20150160A (es) Derivados de macrólidos, su preparación y su uso terapéutico
ECSP14013158A (es) Moduladores alostéricos positivos del receptor de acetilcolina nicotínico

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)